Efficacy and Safety of Stalevo in Subjects With Early Wearing-off Identified Using a Screening Tool WOQ-9; an Open, Non-randomised, Multinational, Multicentre 6-week Direct Switch Study in Levodopa-treated Parkinson's Disease Patients

Trial Profile

Efficacy and Safety of Stalevo in Subjects With Early Wearing-off Identified Using a Screening Tool WOQ-9; an Open, Non-randomised, Multinational, Multicentre 6-week Direct Switch Study in Levodopa-treated Parkinson's Disease Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Levodopa/carbidopa/entacapone (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms SENSE
  • Sponsors Orion
  • Most Recent Events

    • 21 Jan 2008 Status changed from in progress to completed according to ClinicalTrials.gov
    • 12 Oct 2007 The expected completion date for this trial is now 1 Dec 2007.
    • 21 Sep 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top